OSR Health (OSRHW) Other Non Operating Income (2024 - 2026)
OSR Health (OSRHW) posted Other Non Operating Income of $4733.7 for Q1 2026, down 99.89% sequentially from $4.1 million in Q4 2025, and down 82.13% YoY from $26494.3 in Q1 2025.
OSR Health (OSRHW) Other Non Operating Income (2024 - 2026) Analysis & Trends
OSR Health has reported Other Non Operating Income for 3 years, with the latest figure at $4733.7 in Q1 2026.
- Quarterly Other Non Operating Income fell 82.13% year-over-year to $4733.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (up 3068.57% YoY) and the FY2025 annual result came in at $4.3 million, up 4271.12% from the prior year.
- Other Non Operating Income fell to $4733.7 in Q1 2026 per OSRHW's latest filing, from $4.1 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $4.1 million in Q4 2025 and troughed at $3236.0 in Q4 2024.
- A 3-year average of $503765.2 and a median of $26494.3 in 2025 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2025 and 2026: Other Non Operating Income jumped 127123.05% in 2025, then slumped 82.13% in 2026.
- Over 3 years, Other Non Operating Income stood at $3236.0 in 2024, then surged by 127123.05% to $4.1 million in 2025, then slumped by 99.89% to $4733.7 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $4733.7, $4.1 million, and $24250.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.12 Bn | 131.27 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.30 Bn | 77.31 Bn | 3.93 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.66 Bn | 1.37 Bn |
| 4 | Moderna | 55.67 Bn | 50.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.43 Bn | 36.33 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.47 Bn | 9.08 Bn | 668.28 Mn |
| 8 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - |
| 9 | Insmed | 27.03 Bn | 25.87 Bn | 358.27 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,733.70 |
| Dec 31, 2025 | 4.12 Mn |
| Sep 30, 2025 | 24,250.00 |
| Jun 30, 2025 | 223,297.00 |
| Mar 31, 2025 | 26,494.26 |
| Dec 31, 2024 | 3,236.00 |
| Sep 30, 2024 | 82,221.00 |
| Jun 30, 2024 | 25,941.00 |
| Mar 31, 2024 | 26,776.00 |